Cellectar Biosciences has recently unveiled its strategic initiatives for 2025, showcasing their ambitious plans at the Biotech Showcase during the JP Morgan Healthcare Conference, aiming to transform cancer treatment. The company is focused on advancing its lead radiotherapeutic agent, iopofosine
The J.P. Morgan Healthcare Conference held every January at the Westin St. Francis in San Francisco marks a critical event for the healthcare industry. This conference draws biopharma and health system executives, investors, reporters, and a myriad of stakeholders. It acts as a forum to examine
Advanced Micro Devices Inc. (NASDAQ: AMD), a leading semiconductor company, has recently ventured into the life sciences sector through a strategic partnership with Absci Corp. (NASDAQ: ABSI), an AI-based drug developer. This collaboration marks AMD’s first significant move into this domain, aiming
Cell sorting technologies have significantly evolved since the mid-20th century, transforming rudimentary methods into sophisticated systems fundamental to modern biological and medical research. These technologies enable the precise isolation and detailed characterization of single cells,
The intricate relationship between diet, weight, and metabolism has long been a subject of scientific inquiry. Recent research led by Jonathan Long, a biochemist at Stanford University, delves into how specific dietary components influence bodily functions, particularly in terms of energy balance
Private equity (PE) investments in the healthcare and life sciences sector have become increasingly attractive due to the sector's potential for high returns. However, navigating this complex landscape requires a deep understanding of the unique challenges and opportunities it presents. The
